CD25/IL-2R alpha Antibody (Daclizumab) - Chimeric - Azide and BSA Free, Novus Biologicals™

CD25/IL-2 R alpha

Monoclonal

Unconjugated

PBS with 0.02% Proclin 300. with 0.02% Proclin 300

IL2RA

Cultured T-cells derived from a patient with Mycosis fungoides.

0.2 mg

Adaptive Immunity, Apoptosis, B Cell Development and Differentiation Markers, Biologically Active Proteins, Cytokine Research, Diabetes Research, Immunology, Innate Immunity, Mast Cell Markers, Signal Transduction

3559

Human

Purified

Flow Cytometry, Blocking Assay, CyTOF

Daclizumab

Flow Cytometry 1:10 - 1:1000, Blocking/Neutralizing 50 - 200 molar excess, CyTOF-ready

CD25, CD25 antigen, IDDM10, IL-2 receptor subunit alpha, IL2R, IL-2R subunit alpha, IL-2-RA, IL2-RA, interleukin 2 receptor, alpha, interleukin-2 receptor subunit alpha, p55, TAC antigen, TCGFR

Rabbit

Protein A or G purified

RUO

Primary

Binds to p55 chain of IL2R on human T cells, Tac antigen, which is expressed on T cells activated by mitogens, soluble antigens, and alloantigens but not on resting T cells, thymocytes, B cells, monocytes, activated B cells, leukemic T cell blasts from patients with acute lymphoblastic leukemia, and long-term T cell lines.

Store at 4C for up to 3 months. For longer storage, aliquot and store at -20C.

IgG